FrancophonIA/ELRC3.0 huggingface dataset:
English: 5 ml round low density polyethylene bottle with a dispensing plug and white polypropylene screw cap containing 5 ml suspension.
Slovenian: 5 ml okrogel kapalni vsebnik iz polietilena nizke gostote s kapalnim delom in belo polipropilensko navojno zaporko, ki vsebuje 5 ml suspenzije.
English: Clinical trial experience for the long-term use of NEVANAC for the prevention of macular oedema post cataract surgery in diabetic patients is limited.
Slovenian: Izkušnje iz kliničnih preskušanj za dolgoročno uporabo zdravila NEVANAC za preprečevanje makularnega edema po operaciji katarakte pri bolnikih s sladkorno boleznijo so omejene.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDATE PACKAGING UNITS
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
English: C-nepafenac to healthy volunteers, urinary excretion was found to be the major route of radioactive excretions, accounting for approximately 85% while faecal excretion represented approximately 6% of the dose.
Slovenian: C označenega nepafenaka pri zdravih prostovoljcih so ugotovili, da je izločanje s sečem poglavitna pot izločanja radioaktivno označenega zdravila iz telesa (približno 85 %), medtem ko se je z blatom izločilo približno 6 % odmerka.
English: Patients with evidence of corneal epithelial breakdown including corneal perforation should immediately discontinue use of NEVANAC and should be monitored closely for corneal health (see section 4.4).
Slovenian: Bolniki z znaki razpada roženičnega epitelija vključno s perforacijo roženice morajo takoj prenehati uporabljati zdravilo NEVANAC, nato pa je treba stanje roženice skrbno spremljati (glejte poglavje 4.4).
English: This medicine contains 0.15 mg benzalkonium chloride in each 3 ml which is equivalent to 0.05 mg/ml.
Slovenian: To zdravilo vsebuje 0,15 mg benzalkonijevega klorida v 3 ml, kar je enako 0,05 mg/ml.
English: Only use NEVANAC for your eyes.
Slovenian: Zdravilo NEVANAC smete uporabljati le za oči.
English: Patients treated with NEVANAC were less likely to have ocular pain and measurable signs of inflammation (aqueous cells and flare) in the early postoperative period through to the end of treatment than those treated with its vehicle.
Slovenian: Pri bolnikih, ki so se zdravili z zdravilom NEVANAC, je bilo manj verjetno, da bi imeli očesno bolečino in merljive znake vnetja (vodne celice in motnjave) v zgodnjem pooperativnem obdobju ter vse do konca zdravljenja kot pa pri tistih, ki so prejemali vehikel.
English: Each pack contains one bottle of 3 ml.
Slovenian: Vsako pakiranje vsebuje en kapalni vsebnik s 3 ml.
English: Prevention and treatment of postoperative pain and inflammation associated with cataract surgery The efficacy and safety of NEVANAC 3 mg/ml in the prevention and treatment of postoperative pain and inflammation associated with cataract surgery has been demonstrated in two masked, double blind, placebo-controlled clinical trials in a total of 1339 patients.
Slovenian: Preprečevanje in zdravljenje pooperativne bolečine in vnetja, povezanih z operacijo katarakte Varnost in učinkovitost zdravila NEVANAC 3 mg/ml za preprečevanje in zdravljenje pooperativne bolečine in vnetja, povezanega z operacijo katarakte, so dokazali v dveh maskiranih, dvojno slepih, s placebom nadzorovanih kliničnih preskušanjih, v katerih je sodelovalo skupaj 1339 bolnikov.
English: The bottle may be presented in a pouch.
Slovenian: Kapalni vsebnik je lahko pakiran v vrečko.
English: The safety and efficacy of NEVANAC in children and adolescents have not been established.
Slovenian: Varnost in učinkovitost zdravila NEVANAC pri otrocih in mladostnikih nista bili dokazani.
English: In clinical studies involving over 1900 patients receiving NEVANAC 3 mg/ml eye drops, suspension, the most frequently reported adverse reactions were punctate keratitis, keratitis, foreign body sensation in eyes and eye pain which occurred in between 0.4% and 0.1% of patients.
Slovenian: V kliničnih študijah, v katerih je sodelovalo več kot 1900 bolnikov, ki so prejemali zdravilo NEVANAC 3 mg/ml kapljice za oko, suspenzija, so bili neželeni učinki, o katerih so najpogosteje poročali, točkasti keratitis, keratitis, občutek tujka v očeh in očesna bolečina, pojavili pa so se pri 0,4 % do 0,1 % bolnikov.
English: A greater percentage of patients treated with vehicle experienced a decrease in BCVA of more than 5 letters from day 7 to day 90 (or early exit) (11.5%) compared with patients treated with nepafenac (5.6%).
Slovenian: Pri bolnikih, ki so dobivali vehikel, je bil odstotek zmanjšanja najboljše korigirane ostrine vida za več kot 5 črk od 7 do 90 dneva (ali predčasne prekinitve) (11,5 %) večji pri bolnikih, ki so dobivali vehikel, v primerjavi z bolniki, zdravljenimi z nepafenakom (5,6 %).
English: The majority of hydrolytic conversion is in the retina/choroid followed by the iris/ciliary body and cornea, consistent with the degree of vascularised tissue.
Slovenian: Večji del hidrolitične pretvorbe zdravila poteka v mrežnici in žilnici, temu pa sledijo šarenica in ciliarnik ter roženica, kar je v skladu s stopnjo vaskularizacije tkiva.
English: In integrated analysis of the 2 studies, the percentage of subjects with 15 letter improvement at Day 14 and maintained to Day 90 was higher in NEVANAC 3 mg/ml group (55.4%) compared to vehicle group (46.7%, p=0.003).
Slovenian: V združeni analizi obeh študij pa je bil odstotek preiskovancev z izboljšanjem za 15 črk na 14. dan, ki se je ohranjal do 90. dneva, višji v skupini z zdravilom NEVANAC 3 mg/ml (55,4 %) kot pa v skupini z vehiklom (46,7 %, p=0,003).
English: NEVANAC can be used during breast-feeding.
Slovenian: Zdravilo NEVANAC se lahko uporablja med dojenjem.
English: In one double-masked, randomised, vehicle and active-controlled study, patients treated with NEVANAC had significantly less inflammation than those treated with vehicle.
Slovenian: V eni dvojno slepi, randomizirani in z vehiklom ter drugim zdravilom nadzorovani študiji so imeli bolniki, zdravljeni z zdravilom NEVANAC, bistveno manj vnetja kot tisti, ki so se zdravili z vehiklom.
English: If you are worried talk to your doctor or pharmacist.
Slovenian: Če vas skrbi, se pogovorite s svojim zdravnikom ali s farmacevtom.
English: How to use NEVANAC
Slovenian: Kako uporabljati zdravilo NEVANAC
English: Results from clinical studies indicate that NEVANAC 3 mg/ml eye drops, suspension have no significant effect on intraocular pressure.
Slovenian: Izsledki kliničnih študij kažejo, da zdravilo NEVANAC 3 mg/ml kapljice za oko, suspenzija nima bistvenega učinka na očesni tlak.
English: Prevention and treatment of postoperative pain and inflammation associated with cataract surgery Three pivotal studies were conducted to assess the efficacy and safety of NEVANAC dosed 3 times daily as compared to vehicle and/or ketorolac trometamol in the prevention and treatment of postoperative pain and inflammation in patients undergoing cataract surgery.
Slovenian: Preprečevanje in zdravljenje pooperativne bolečine in vnetja, povezanih z operacijo katarakte Opravljene so bile tri ključne študije za oceno varnosti in učinkovitosti zdravila NEVANAC, ki so si ga bolniki odmerili v oko 3-krat na dan, v primerjavi z vehiklom in/ali ketorolak trometamolom za preprečevanje in zdravljenje pooperativne bolečine in vnetja pri bolnikih, ki so imeli operacijo katarakte.
English: NEVANAC contains benzalkonium chloride
Slovenian: Zdravilo NEVANAC vsebuje benzalkonijev klorid
English: • Do not squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs
Slovenian: • Ne stiskajte kapalnega vsebnika, ker je izdelan tako, da zadošča že rahel pritisk na njegovo dno
English: The medicinal product should not be injected.
Slovenian: Zdravila ne smete injicirati.
English: Nepafenac is a non-steroidal anti-inflammatory and analgesic prodrug.
Slovenian: Nepafenak je nesteroidno protivnetno in protibolečinsko predzdravilo.
English: NEVANAC has not been studied in patients with hepatic disease or renal impairment.
Slovenian: Zdravila NEVANAC niso raziskovali pri bolnikih z jetrno ali ledvično okvaro.
English: A significantly higher percentage of patients in the NEVANAC group reported no ocular pain following cataract surgery compared to those in the vehicle group.
Slovenian: V skupini, ki je uporabljala zdravilo NEVANAC, so opazili bistveno večji odstotek tistih bolnikov, ki po operaciji katarakte niso poročali o očesnih bolečinah, kakor v skupini z vehiklom.
English: In both double-masked, randomised vehicle-controlled studies, conducted in diabetic retinopathy patients, a significantly greater percentage of patients in the vehicle group developed macular oedema (17.3% and 14.3%) compared to patients treated with NEVANAC 3 mg/ml (2.3% and 5.9%).
Slovenian: V obeh dvojno slepih, randomiziranih, z vehiklom nadzorovanih študijah, izvedenih pri bolnikih s sladkorno boleznijo z diabetično retinopatijo, se je makularni edem pojavil pri znatno večjem odstotku bolnikov v skupini z vehiklom (17,3 % in 14,3 %) v primerjavi z bolniki, zdravljenimi z zdravilom NEVANAC 3 mg/ml kapljice za oko, suspenzija (2,3 % in 5,9 %).
English: There have been reports that ophthalmic NSAIDs may cause increased bleeding of ocular tissues (including hyphaemas) in conjunction with ocular surgery.
Slovenian: Objavljena so bila poročila, da lahko pri kirurških posegih na očesu NSAID za okularno uporabo povzročijo povečane krvavitve v očesna tkiva (vključno s hifemami).
English: The European Medicines Agency has waived the obligation to submit the results of studies with NEVANAC in all subsets of the paediatric population in prevention and treatment of post operative pain and inflammation associated with cataract surgery (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom NEVANAC za vse podskupine pediatrične populacije za preprečevanje in zdravljenje pooperativne bolečine in vnetja, povezanega z operacijo katarakte (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: • Pull down your lower eyelid with a clean finger, until there is a ‘pocket' between the eyelid and your eye.
Slovenian: • S čistim prstom potegnite spodnjo veko navzdol, da med veko in očesom nastane 'žepek', kamor boste vkapali kapljico (slika 1).
English: You may find that your vision is blurred for a time just after using NEVANAC.
Slovenian: Vaš vid bo lahko zamegljen še nekaj časa po uporabi zdravila NEVANAC.
English: NEVANAC 3 mg/ml eye drops, suspension is indicated in adults for:
Slovenian: Zdravilo NEVANAC 3 mg/ml kapljice za oko, suspenzija je indicirano pri odraslih za:
English: Round or oval low density polyethylene bottle with a dispensing plug and white polypropylene screw cap containing 3 ml suspension.
Slovenian: Okrogel ali ovalen kapalni vsebnik iz polietilena nizke gostote s kapalnim delom in belo polipropilensko navojno zaporko, ki vsebuje 3 ml suspenzije.
English: Some patients received NEVANAC 3 mg/ml eye drops, suspension for up to 21 days post operation.
Slovenian: Nekaj bolnikov je prejemalo zdravilo NEVANAC 3 mg/ml kapljice za oko, suspenzija do 21. dne po operaciji.
English: Four studies (two in diabetic patients and two in non-diabetic patients) were conducted to assess the efficacy and safety of NEVANAC for the prevention of postoperative macular oedema associated with cataract surgery.
Slovenian: Izvedli so štiri študije (dve z bolniki s sladkorno boleznijo in dve z bolniki brez sladkorne bolezni) za ocenitev varnosti in učinkovitosti zdravila NEVANAC za preprečevanje pooperativnega makularnega edema, povezanega z operacijo katarakte.
English: If a dose is missed, a single drop should be applied as soon as possible before reverting to regular routine.
Slovenian: Če bolnik izpusti posamezen odmerek, naj si čimprej vkapa eno kapljico zdravila, potem pa naj nadaljuje z rednim režimom odmerjanja zdravila.
English: Patients in whom attacks of asthma, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or other NSAIDs.
Slovenian: Bolniki, pri katerih acetilsalicilna kislina ali drugi NSAID sprožijo napad astme, urtikarije ali akutnega rinitisa.
English: In two double-masked, randomised vehicle-controlled studies, patients treated with NEVANAC had significantly less inflammation (aqueous cells and flare) in the early postoperative period through the end of treatment than those treated with its vehicle.
Slovenian: V dveh dvojno slepih, randomiziranih in z vehiklom nadzorovanih študijah so imeli bolniki, zdravljeni z zdravilom NEVANAC, bistveno manj vnetja (vodnih celic in pordelosti) od zgodnjega pooperativnega obdobja do konca zdravljenja kot pa tisti, ki so prejemali njegov vehikel.
English: In the two clinical studies involving 594 patients, diabetic patients were exposed to NEVANAC eye drops, suspension treatment for 90 days for the prevention of macular oedema post cataract surgery.
Slovenian: V dveh kliničnih študijah, v katerih je sodelovalo 594 bolnikov, so bili bolniki s sladkorno boleznijo izpostavljeni 90-dnevnemu zdravljenju z zdravilom NEVANAC kapljice za oko, suspenzija za preprečevanje makularnega edema po operaciji katarakte.
English: The most frequently reported adverse reaction was punctate keratitis which occurred in 1% of patients, resulting in a frequency category of common.
Slovenian: Neželeni učinek, o katerem so najpogosteje poročali, je bil točkasti keratitis, ki se je pojavil pri 1 % bolnikov, zato je bil po pogostnosti razvrščen v kategorijo pogosti.
English: In some susceptible patients, continued use of topical NSAIDs may result in epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration or corneal perforation (see section 4.8).
Slovenian: Pri nekaterih občutljivih bolnikih lahko daljša topikalna uporaba NSAID vodi do razpadanja epitelija, tanjšanja roženice, nastanka erozije ali razjede na roženici ali celo do perforacije roženice (glejte poglavje 4.8).
English: From post-marketing experience with NEVANAC, cases reporting corneal epithelium defect/disorder have been identified.
Slovenian: Iz izkušenj v obdobju trženja z zdravilom NEVANAC so opredelili poročila s primeri okvare/bolezni epitelija roženice.
English: Nepafenac is eliminated primarily through biotransformation and the systemic exposure is very low following topical ocular administration.
Slovenian: Nepafenak se izloča predvsem z biotransformacijo in sistemska izpostavljenost zdravilu po topikalni okularni uporabi je zelo majhna, zato pri teh bolnikih ni potrebna prilagoditev odmerka.
English: Close the bottle cap firmly immediately after use.
Slovenian: Takoj po uporabi kapalni vsebnik spet tesno zaprite z zaporko.
English: Do not use more than one drop in the affected eye(s) 3 times daily.
Slovenian: Ne uporabite dvojnega odmerka, da bi nadomestili izpuščenega in ne vkapajte si več kot eno kapljico v prizadeto oko (oči) trikrat na dan.
English: What NEVANAC contains - The active substance is nepafenac.
Slovenian: Kaj vsebuje zdravilo NEVANAC - Učinkovina je nepafenak.
English: Studies in animals have shown reproductive toxicity (see section 5.3).
Slovenian: Študije na živalih so pokazale vpliv na sposobnost razmnoževanja (glejte poglavje 5.3), morebitno tveganje za človeka pa ni znano.
English: Examples of NSAIDs are: acetylsalicylic acid, ibuprofen, ketoprofen, piroxicam, diclofenac.
Slovenian: Med NSAID sodijo na primer acetilsalicilna kislina, ibuprofen, ketoprofen,
English: What NEVANAC looks like and the contents of the pack NEVANAC is a liquid (light yellow to light orange suspension) supplied in a pack containing one 5 ml plastic bottle with a screw cap.
Slovenian: Izgled zdravila NEVANAC in vsebina pakiranja Zdravilo NEVANAC je tekočina (svetlo rumena do svetlo oranžna suspenzija), ki je na voljo v pakiranjih z enim 5 ml kapalnim vsebnikom z navojno zaporko.
English: From post-marketing experience with NEVANAC 1 mg/ml eye drops, suspension, cases reporting corneal epithelium defect/disorder have been identified.
Slovenian: Iz izkušenj v obdobju trženja z zdravilom NEVANAC 1 mg/ml kapljice za oko, suspenzija so opredelili poročila s primeri okvare/bolezni epitelija roženice.
English: The other reported adverse reactions were corneal epithelium defect and allergic dermatitis which occurred in 1% and 0.5% of patients, respectively both adverse reactions with a frequency category of uncommon.
Slovenian: Druga neželena učinka sta bila okvara epitelija roženice in alergijski dermatitis, ki sta se pojavila pri 1 % oziroma 0,5 % bolnikov, oba v razvrstitvi pogostnosti občasni.
English: The preservative in NEVANAC, benzalkonium chloride, may be absorbed by soft contact lenses and may change the colour of the contact lenses.
Slovenian: Konzervans v zdravilu NEVANAC, benzalkonijev klorid, se lahko absorbira v mehke kontaktne leče in lahko spremeni barvo kontaktnih leč.
English: Nepafenac and amfenac were not quantifiable in the urine.
Slovenian: Količine samega nepafenaka in amfenaka v seču ni bilo mogoče določiti.
English: You may find that your vision is blurred temporarily just after using NEVANAC.
Slovenian: Vaš vid bo lahko začasno zamegljen po uporabi zdravila NEVANAC.
English: Two studies in diabetic patients were conducted to assess the efficacy and safety of NEVANAC 3 mg/ml eye drops, suspension dosed once a day for the prevention of postoperative macular oedema associated with cataract surgery.
Slovenian: Pri bolnikih s sladkorno boleznijo sta bili izvedeni dve študiji za oceno učinkovitosti in varnosti zdravila NEVANAC 3 mg/ml kapljice za oko, suspenzija, odmerjenega enkrat na dan za preprečevanje pooperativnega makularnega edema, povezanega z operacijo katarakte.
English: In 1 double-masked, randomised vehicle-controlled study, conducted in diabetic retinopathy patients, a significantly greater percentage of patients in the vehicle group developed macular oedema (16.7%) compared to patients treated with NEVANAC (3.2%).
Slovenian: V 1 dvojno slepi, randomizirani, z vehiklom nadzorovani študiji, ki so jo izvedli pri bolnikih s sladkorno boleznijo z retinopatijo, je bil odstotek pojava makularnega edema (16,7 %) v skupini z vehiklom večji v primerjavi z bolniki, zdravljenimi z zdravilom NEVANAC (3,2 %).
English: NEVANAC is to be used by adults: - to prevent and relieve eye pain and inflammation following cataract surgery on the eye - to reduce the risk of macular oedema (swelling in the back of the eye) following cataract surgery on the eye in diabetic patients.
Slovenian: Zdravilo NEVANAC uporabljamo pri odraslih: - za preprečevanje in lajšanje očesnih bolečin in vnetja po operaciji katarakte na očesu, - za zmanjšanje tveganja razvoja makularnega edema (otekanje v zadnjem delu očesa) po operaciji katarakte na očesu pri bolnikih s sladkorno boleznijo.
English: After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug.
Slovenian: Po topikalni uporabi zdravila nepafenak prodre v oko skozi roženico in hidrolaze ga v očesnem tkivu pretvorijo v amfenak, nesteroidno protivnetno zdravilo.
English: In the two clinical studies involving 209 patients, diabetic patients were exposed to NEVANAC treatment for 60 days or greater for the prevention of macular oedema post cataract surgery.
Slovenian: V dveh kliničnih študijah, v katerih je sodelovalo 209 bolnikov, so bili bolniki s sladkorno boleznijo izpostavljeni 60- ali večdnevnemu zdravljenju z zdravilom NEVANAC za preprečevanje makularnega edema po operaciji katarakte.
English: In these studies, study medication was initiated the day prior to surgery, continued on the day of surgery and for up to 90 days of the postoperative period.
Slovenian: V teh študijah so zdravilo v študiji uvedli na dan pred operacijo, z dajanjem nadaljevali na dan operacije in še do 90 dni v pooperativnem obdobju.
English: 1 x 3 ml - oval bottle
Slovenian: 1 x 3 ml - ovalni kapalni vsebnik
English: - complicated eye surgery - repeated eye surgery within a short period of time - certain disorders of the surface of the eye, such as inflammation or dry eye - certain general diseases, such as diabetes or rheumatoid arthritis.
Slovenian: - zapleten kirurški poseg na očesu, - več zaporednih kirurških posegov na očesu v kratkem času, - nekatere motnje na površini očesa, na primer vnetje očesa ali suho oko, - nekatere splošne bolezni, na primer sladkorno bolezen ali revmatoidni artritis.
English: In clinical studies involving 2314 patients receiving NEVANAC 1 mg/ml the most common adverse reactions were punctate keratitis, foreign body sensation and eyelid margin crusting which occurred in between 0.4% and 0.2% of patients.
Slovenian: V kliničnih študijah, v katerih je sodelovalo 2314 bolnikov, ki so prejemali zdravilo NEVANAC 1 mg/ml kapljice za oko, so bili najpogostejši neželeni učinki točkasti keratitis, občutek tujka v očeh in kraste na robovih vek, ki so se pojavili pri bolnikih med 0,4 % in 0,2 %.
English: The other most frequently reported adverse reactions were keratitis and foreign body sensation in eyes which occurred in 0.5% and 0.3% of patients, respectively both adverse reactions with a frequency category of uncommon.
Slovenian: Druga neželena učinka, o katerih so najpogosteje poročali, sta bila keratitis in občutek tujka v očeh, ki sta se pojavila pri 0,5 % in 0,3 % bolnikov, in sta bila oba po pogostnosti razvrščena v kategorijo občasni.
English: If you have any further questions on the use of this medicine ask your doctor, pharmacist or nurse.
Slovenian: Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: NEVANAC should not be used by women of child bearing potential not using contraception.
Slovenian: Zdravila NEVANAC ne uporabljajte pri ženskah v rodni dobi, ki ne uporabljajo učinkovite kontracepcije.
English: The European Medicines Agency has waived the obligation to submit the results of studies with NEVANAC in all subsets of the paediatric population in prevention and treatment of post operative pain and inflammation associated with cataract surgery and prevention of post surgical macular oedema (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom NEVANAC za vse podskupine pediatrične populacije za preprečevanje in zdravljenje pooperativne bolečine in vnetja, povezanega z operacijo katarakte, in za preprečevanje tveganja pooperativnega makularnega edema (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: These findings indicate rapid corneal penetration.
Slovenian: Ti izsledki torej kažejo, da zdravilo hitro prodira skozi roženico.
English: What NEVANAC is and what it is used for What you need to know before you use NEVANAC How to use NEVANAC
Slovenian: Kaj je zdravilo NEVANAC in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo NEVANAC Kako uporabljati zdravilo NEVANAC Možni neželeni učinki
English: • Shake well before use.
Slovenian: • Pred uporabo dobro pretresite.
English: Treatment can be extended to the first 3 weeks of the postoperative period as directed by the clinician.
Slovenian: Po zdravnikovem navodilu se zdravljenje lahko podaljša na prve tri tedne pooperativnega obdobja.
English: • Effects in the eye: eye surface inflammation with or without loss or damage of cells, foreign body sensation in the eyes, eyelid crusting or drooping.
Slovenian: • Učinki v očesu: vnetje površine očesa z ali brez izgube ali poškodbe celic, občutek tujka v očeh, kraste na robovih vek ali povešena veka
English: Carton containing 1 bottle.
Slovenian: Škatla vsebuje en kapalni vsebnik.
English: Patients should be instructed to shake the bottle well before use.
Slovenian: Bolnikom morate svetovati, da pred uporabo dobro pretresejo kapalni vsebnik.
English: The adverse reactions were obtained from clinical trials or post-marketing reports with NEVANAC 3 mg/ml eye drops, suspension and NEVANAC 1 mg/ml eye drops, suspension.
Slovenian: Neželeni učinki so bili ugotovljeni v kliničnih preskušanjih ali iz poročil v obdobju trženja zdravila NEVANAC 3 mg/ml kapljice za oko, suspenzija in zdravila NEVANAC 1 mg/ml kapljice za oko, suspenzija.